ResearcherUniversity of TsukubaNo recent work listed
Sota Kimura
Matched on ORCID iD 0000-0001-5878-4459; OpenAlex author ID A5037916115. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 1 paper
Papers 3
- Carcinoembryonic antigen as a specific glycoprotein ligand of rBC2LCN lectin on pancreatic ductal adenocarcinoma cells. Co-author DOI 10.1111/cas.15023↗
- Novel Pancreatic Cancer Therapy Targeting Cell Surface Glycans by Liposomes Modified with rBC2LCN Lectin. Co-author DOI 10.1159/000513430↗
- A Novel Therapeutic Strategy for Pancreatic Cancer: Targeting Cell Surface Glycan Using rBC2LC-N Lectin-Drug Conjugate (LDC). Co-author DOI 10.1158/1535-7163.mct-17-0232↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tatsuya Oda · 3 shared papers, 2018–2021 · strength 0.30
- Paper Carcinoembryonic antigen as a specific glycoprotein ligand of rBC2LCN lectin on pancreatic ductal adenocarcinoma cells. DOI 10.1111/cas.15023↗
- Paper Novel Pancreatic Cancer Therapy Targeting Cell Surface Glycans by Liposomes Modified with rBC2LCN Lectin. DOI 10.1159/000513430↗
- Paper A Novel Therapeutic Strategy for Pancreatic Cancer: Targeting Cell Surface Glycan Using rBC2LC-N Lectin-Drug Conjugate … DOI 10.1158/1535-7163.mct-17-0232↗
- Osamu Shimomura · 3 shared papers, 2018–2021 · strength 0.30
- Paper Carcinoembryonic antigen as a specific glycoprotein ligand of rBC2LCN lectin on pancreatic ductal adenocarcinoma cells. DOI 10.1111/cas.15023↗
- Paper Novel Pancreatic Cancer Therapy Targeting Cell Surface Glycans by Liposomes Modified with rBC2LCN Lectin. DOI 10.1159/000513430↗
- Paper A Novel Therapeutic Strategy for Pancreatic Cancer: Targeting Cell Surface Glycan Using rBC2LC-N Lectin-Drug Conjugate … DOI 10.1158/1535-7163.mct-17-0232↗
- Hiroaki Tateno · 3 shared papers, 2018–2021 · strength 0.30
- Paper Carcinoembryonic antigen as a specific glycoprotein ligand of rBC2LCN lectin on pancreatic ductal adenocarcinoma cells. DOI 10.1111/cas.15023↗
- Paper Novel Pancreatic Cancer Therapy Targeting Cell Surface Glycans by Liposomes Modified with rBC2LCN Lectin. DOI 10.1159/000513430↗
- Paper A Novel Therapeutic Strategy for Pancreatic Cancer: Targeting Cell Surface Glycan Using rBC2LC-N Lectin-Drug Conjugate … DOI 10.1158/1535-7163.mct-17-0232↗
- Tomoaki Furuta · 2 shared papers, 2020–2021 · strength 0.23
- Yoshihiro Miyazaki · 2 shared papers, 2020–2021 · strength 0.23
- Yoshimasa Akashi · 1 shared paper, 2021 · strength 0.12
- Yukihito Kuroda · 1 shared paper, 2020 · strength 0.11
- Tsuyoshi Enomoto · 1 shared paper, 2020 · strength 0.11
- Nobuhiro Ohkohchi · 1 shared paper, 2018 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.